Frontotemporal Disorders Treatment Market: Government Initiatives to Advance Neurological Disease Treatments Fuelling Revenue Growth: Global Industry Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028

  • Published: 2018-12-12
  • Report Code: REP-GB-5033
  1. Home
  2. Syndicated Research

  3. Frontotemporal Disorders Treatment Market Outlook 2019

An Incisive, In-depth Analysis on the Frontotemporal Disorders Treatment Market

This study offers a comprehensive, 360 degree analysis on the Frontotemporal Disorders Treatment market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Frontotemporal Disorders Treatment market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.

Request a sample
Ask An Analyst
Request Special Price
Request Methodology

Increasing FTD Drug Development Grants and Funding by Non-Profit Organisations

Non-profit organizations, disease advocacy and private organizations currently are focusing on to support the frontotemporal disorders treatment drug development as the patient base of FTD is expanding. Research funding initiatives by non-profit organization such as the Association for Frontotemporal Degeneration (AFTD), Alzheimer Discovery Foundation (ADDF), Bluefield Project Organization, Tau Consortium Organization, CurePSP, Inc. have helped to promote frontotemporal disorders treatment drugs research initiatives. These organizations support clinical or preclinical studies for testing new therapeutics which are interventional to slow or stop FTD and other neurological disease progression.

Growing Prevalence of Dementia Expected to Propel the Demand for Frontotemporal Disorders Treatment Drugs

Dementia affects around 50 million people globally. Frontotemporal dementia may account for 2–5% of the overall dementia cases. Dementia prevalence is projected to nearly triple by 2050. According to the Dementia Statistics Organization, globally the number of people living with dementia will increase by 204% from 50 Mn in 2018 to 152 Mn in 2050. The growing number of dementia cases will also increase the population base of frontotemporal dementia, which is expected to propel the demand for frontotemporal disorders treatment drugs and medications.

Orphan Drug Development Incentives by FDA Expected to Increase Drug Developer Interest Towards Frontotemporal Disorders Treatment Drug Development

Frontotemporal dementia falls under the rare diseases or orphan indications. FTD affects around 30,000 to 40,000 patients in the U.S. Treatment of FTD falls under the auspices of Orphan Drug Act of 1983 as orphan drug indications are those which affect less than 200,000 people in the U.S. along with similar legislation in the Europe. Orphan drug designation to FTD allows the continuation of clinical trial and drug development with commercial incentives, prioritized consultation by FDA on clinical studies and reduction in regulatory fees.

High Life Expectancy Rate Leads to Higher Prevalence of Frontotemporal Disorders in the Older Age Group

Rising life expectancy rate is another major factor expected to boost the growth of the frontotemporal disorders treatment market due to high prevalence of frontotemporal disorder among the older population. Population aged 65 years and above is mostly prone to neurodegenerative diseases such frontotemporal disorder, Alzheimer and dementia. The global population is projected to increase over the time. Global population in 2015 was around 7.2 Bn and is estimated to grow to around 15 Bn in 2050. People aged 65 and above is one of the fast growing demographics across the globe. Frontotemporal dementia affects around 6.5 people in 100,000 over the age of 65 annually.

Competitive Landscape

This section of the report features profiles of the key players operating in the frontotemporal disorders treatment market based on their market shares, differential strategies, product offerings, marketing approach, and company dashboard. Examples of some of the frontotemporal disorders treatment market key players featured in this report includes Pfizer Inc., Johnson & Johnson, Sanofi S.A., Eli Lilly and Company, GlaxoSmithKline Plc., Novartis AG, Mylan N.V., Merck & Company, Inc., AstraZeneca plc., and Allergen plc, among others. Many companies in the frontotemporal disorders treatment market are aiming on clinical studies and trials for new drug development.

Definition

Frontotemporal disorders are a bunch of rare disorders that include shrinkage of particular portion of the brain, which controls personality, language, and behavior. The condition rises due to degeneration of frontotemporal cells, which are named as frontotemporal lobar degeneration (FTLD). The typical age range for onset of frontotemporal dementia is 40 to 60 years of age, however, it can start after 60 years of age and the maximum life expectancy after diagnosis is 8–10 years.

About the Report

The company conducted a research study on the frontotemporal disorders treatment market for the forecast period 2018 to 2028. The report offers a comprehensive evaluation of the business opportunities prevailing in the frontotemporal disorders treatment market along with insights on the market dynamics, market trend and opportunities, pipeline analysis, disease epidemiology and others. The frontotemporal disorders treatment market report elaborates the macroeconomic factors influencing the dynamics of frontotemporal disorders treatment market and its futuristic potential.

Segmentation

The report offers a comprehensive taxonomy of the frontotemporal disorders treatment market based on drug class, treatment type, disease indication, distribution channel and region. By drug class, the frontotemporal disorders treatment market is segmented into cognitive enhancers, antipsychotics, antidepressants, CNS stimulants, and others. By treatment type, the frontotemporal disorders treatment market is segmented into behavioral symptom management and psychological symptoms management segment. By disease indication, the frontotemporal disorders treatment market is segmented into frontotemporal dementia, primary progressive aphasia, and movement disorders segment. By distribution channel, the frontotemporal disorders treatment market is segmented into hospital pharmacies, retail pharmacy, drug stores and online pharmacy. The frontotemporal disorders treatment market has been analyzed across seven regions including North America, Latin America, Western Europe, Eastern Europe, and Asia Pacific excluding Japan (APEJ), Japan and Middle East & Africa (MEA).

Additional Questions Answered

Some of the additional questions addressed in this report on the frontotemporal disorders treatment market-

  • Who are the key competitors and their product portfolio and strategy in frontotemporal disorders treatment market?

  • What are major challenges influencing the growth of frontotemporal disorders treatment market?

  • What are major trends in the frontotemporal disorders treatment market?

Research Methodology

The frontotemporal disorders treatment market has been estimated based on epidemiology-based model and adoption of different symptomatic drugs. The market value was first calculated based on epidemiology of frontotemporal dementia in different region/countries. The frontotemporal disorders treatment market value was estimated based on adoption of different drugs for behavioral and psychological symptoms management, pricing analysis, and epidemiology in top 20 countries globally. Other qualitative factors analyzed are pipeline analysis, regulatory policies, neurological healthcare expenditure related to frontotemporal disorders treatment. This information is further validated with rigorous primary research (including in-person interactions, interviews, surveys and viewpoints of seasoned analysts) and secondary research (including authentic trade journals, verified paid sources and resourceful databases). The research study on frontotemporal disorders treatment market also includes top trends and macro as well as microeconomic factors shaping the frontotemporal disorders treatment market. With this approach, the report on frontotemporal disorders treatment market anticipates the industry attractiveness of every major segment in frontotemporal disorders treatment over the forecast period.

A recent market study published by company – “Frontotemporal Disorders Treatment Market: Global Industry Analysis 2013–2017 & Opportunity Assessment 2018–2028” – consists of a comprehensive assessment of the most important market dynamics. On conducting a thorough research on the historic as well as current growth parameters of the frontotemporal disorders treatment market, growth prospects of the market are obtained with maximum precision. The report features unique and salient factors that may have a huge impact on the development of the frontotemporal disorders treatment market during the forecast period. It can help market players to modify their manufacturing and marketing strategies to envisage maximum growth in the frontotemporal disorders treatment market in the upcoming years. The report provides detailed information about the current and future growth prospects of the frontotemporal disorders treatment market in the most comprehensive way for the better understanding of readers.

Chapter 01 – Executive Summary

The report commences with the executive summary of the frontotemporal disorders treatment market, which includes the summary of key findings and key statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the frontotemporal disorders treatment market.

Chapter 02 – Market Overview

Readers can find detailed taxonomy and the definition of the frontotemporal disorders treatment market in this chapter, which will help readers to understand the basic information about the frontotemporal disorders treatment outlook and list of key market participants included in the report.

Chapter 03 – Market Dynamics

Readers can find detailed market dynamics of the frontotemporal disorders treatment market in this chapter, which will help readers to understand the basic information about the frontotemporal disorders treatment market dynamics such as drivers, restraints, opportunity and trends included in the report.

Chapter 04 – Key Inclusions

This chapter includes detailed analysis epidemiology of frontotemporal disorders and key regulatory scenario of global frontotemporal disorders treatment market along with region wise assessment.

Chapter 05 – North America Frontotemporal Disorders Treatment Market Analysis 2013–2017 & Opportunity Assessment 2018–2028

This chapter includes detailed analysis of the growth of the North America frontotemporal disorders treatment market along with the country-wise assessment including the U.S. and Canada. Readers can also find regional trends, regulations, and market growth based drug class, treatment type, diseases indication, distribution channel and countries in the North America frontotemporal disorders treatment market.

Chapter 06 – Latin America Frontotemporal Disorders Treatment Market Analysis 2013–2017 & Opportunity Assessment 2018–2028

Readers can find detailed information about factors such as regional trends that are impacting the growth of the Latin America frontotemporal disorders treatment market. This chapter also includes the growth prospects of the frontotemporal disorders treatment market in leading LATAM countries such as Brazil, Mexico, and Rest of Latin America.

Chapter 07 – Western Europe Frontotemporal Disorders Treatment Market Analysis 2013–2017 & Opportunity Assessment 2018–2028

Important growth prospects of the frontotemporal disorders treatment market based on its drug class, treatment type, diseases indication, distribution channel in several Western European countries, such as Germany, the U.K., France, Italy, Spain and rest of Western Europe is included in this chapter.

Chapter 08 – Eastern Europe Frontotemporal Disorders Treatment Market Analysis 2013–2017 & Opportunity Assessment 2018–2028

Important growth prospects of the frontotemporal disorders treatment market based on its drug class, treatment type, diseases indication, distribution channel in several Eastern European countries, such as Russia, Poland and Rest of Eastern Europe are included in this section.

Chapter 09 – APEJ Frontotemporal Disorders Treatment Market Analysis 2013–2017 & Opportunity Assessment 2018–2028

India, ASEAN, Japan Australia and New Zealand are the leading countries in the APEJ region that are the prime subject of assessment to obtain growth prospects of the APEJ frontotemporal disorders treatment market in this chapter. Readers can find thorough information about the growth parameters of the APEJ frontotemporal disorders treatment market during the period 2018–2028.

Chapter 10 – Japan Frontotemporal Disorders Treatment Market Analysis 2013–2017 & Opportunity Assessment 2018–2028

Readers can find important factors that can make a huge impact on the growth of the frontotemporal disorders treatment market in Japan based on the market segmentation, during the forecast period. This chapter provides the overview of regulations, drivers, restraints, and trends in the Japan frontotemporal disorders treatment market.

Chapter 11 – MEA Frontotemporal Disorders Treatment Market Analysis 2013–2017 & Opportunity Assessment 2018–2028

This chapter provides information on how the frontotemporal disorders treatment market will grow in the major countries in MEA region, such as GCC Countries, South Africa, during the period 2018–2028.

Chapter 12 – Competition Landscape and Company Profiles

In this chapter, readers can find a comprehensive list of all the leading stakeholders in the frontotemporal disorders treatment market along with detailed information about each company, including company overview, revenue shares, strategic overview, and recent company developments. Market players featured in the report includes Pfizer Inc., Johnson & Johnson, Sanofi S.A., Eli Lilly and Company, GlaxoSmithKline Plc., Novartis AG, Mylan N.V., Merck & Company, Inc., AstraZeneca plc., and Allergen plc., among others.

Chapter 13 – Global Frontotemporal Disorders Treatment Market Analysis 2013–2017 & Opportunity Assessment 2018–2028, By Region

This chapter explains how the frontotemporal disorders treatment market will grow across various geographic regions, such as North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific Excluding Japan (APEJ), Japan, and the Middle East & Africa (MEA).

Chapter 14 – Global Frontotemporal Disorders Treatment Market Analysis 2013–2017 & Opportunity Assessment 2018–2028, By Drug Class

Based on the drug class, the frontotemporal disorders treatment market is segmented into cognitive enhancers, antipsychotics, antidepressants, CNS stimulants, and others. In this chapter, readers can find information about key trends and developments in the frontotemporal disorders treatment market and market attractive analysis based on the drug class.

Chapter 15 – Global Frontotemporal Disorders Treatment Market Analysis 2013–2017 & Opportunity Assessment 2018–2028, By Treatment Type

Based on the treatment type, the frontotemporal disorders treatment market is segmented into behavioral symptom management and psychological symptoms management segment. In this chapter, readers can find information about key trends and developments in the frontotemporal disorders treatment market and market attractive analysis based on treatment type.

Chapter 16 – Global Frontotemporal Disorders Treatment Market Analysis 2013–2017 & Opportunity Assessment 2018–2028, By Disease Indication

Based on the disease indication, the frontotemporal disorders treatment market is segmented into frontotemporal dementia, primary progressive aphasia, and movement disorders segment. In this chapter, readers can find information about key trends and developments in the frontotemporal disorders treatment market and market attractive analysis based on disease indication.

Chapter 17 – Global Frontotemporal Disorders Treatment Market Analysis 2013–2017 & Opportunity Assessment 2018–2028, By Distribution Channel

Based on the distribution channel, the frontotemporal disorders treatment market is segmented into hospital pharmacies, retail pharmacy, drug stores, and online pharmacy. In this chapter, readers can find information about key trends and developments in the frontotemporal disorders treatment market and market attractive analysis based on distribution channel.

Chapter 18 – Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.

Chapter 19 – Research Methodology

This chapter helps readers to understand the research methodology followed to obtain various conclusions, important qualitative information, and quantitative information about the frontotemporal disorders treatment market.

Frontotemporal Disorders Treatment Market Reports - Table of Contents

Frontotemporal Disorders Treatment Market Reports - List of Tables

  1. NIH Estimated Funding for Frontotemporal Dementia

  2. Frontotemporal Disorders Treatment Market Opportunity Pipeline Analysis (2017)

  3. Frontotemporal Disorders Treatment Market Opportunity Pipeline Analysis (2017)

  4. Non-Profit Organizations Driving FTD Therapeutics Development

  5. Non-Profit Organizations Driving FTD Therapeutics Development

  6. World Population Aged 65 and Over by Sex: 2015, 2030, and 2050 (Numbers in millions)

  7. Prevalence of Frontotemporal Dementia, By Region

  8. Prevalence of Frontotemporal Dementia, By Region

  9. Prevalence of Primary Progressive Aphasia , By Region

  10. Prevalence of Primary Progressive Aphasia , By Region

  11. North America Frontotemporal Disorders Treatment Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Country

  12. North America Frontotemporal Disorders Treatment Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Drug Class

  13. North America Frontotemporal Disorders Treatment Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Treatment Type

  14. North America Frontotemporal Disorders Treatment Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Disease Indication

  15. North America Frontotemporal Disorders Treatment Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Distribution Channel

  16. Latin America Frontotemporal Disorders Treatment Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Country

  17. Latin America Frontotemporal Disorders Treatment Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Drug Class

  18. Latin America Frontotemporal Disorders Treatment Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Treatment Type

  19. Latin America Frontotemporal Disorders Treatment Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Disease Indication

  20. Latin America Frontotemporal Disorders Treatment Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Distribution Channel

  21. Western Europe Frontotemporal Disorders Treatment Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Country

  22. Western Europe Frontotemporal Disorders Treatment Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Drug Class

  23. Western Europe Frontotemporal Disorders Treatment Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Treatment Type

  24. Western Europe Frontotemporal Disorders Treatment Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Disease Indication

  25. Western Europe Frontotemporal Disorders Treatment Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Distribution Channel

  26. Eastern Europe Frontotemporal Disorders Treatment Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Country

  27. Eastern Europe Frontotemporal Disorders Treatment Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Drug Class

  28. Eastern Europe Frontotemporal Disorders Treatment Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Treatment Type

  29. Eastern Europe Frontotemporal Disorders Treatment Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Disease Indication

  30. Eastern Europe Frontotemporal Disorders Treatment Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Distribution Channel

  31. APEJ Frontotemporal Disorders Treatment Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Country

  32. APEJ Frontotemporal Disorders Treatment Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Drug Class

  33. APEJ Europe Frontotemporal Disorders Treatment Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Treatment Type

  34. APEJ Europe Frontotemporal Disorders Treatment Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Disease Indication

  35. APEJ Europe Frontotemporal Disorders Treatment Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Distribution Channel

  36. Japan Frontotemporal Disorders Treatment Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Drug Class

  37. Japan Europe Frontotemporal Disorders Treatment Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Treatment Type

  38. Japan Europe Frontotemporal Disorders Treatment Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Disease Indication

  39. Japan Europe Frontotemporal Disorders Treatment Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Distribution Channel

  40. MEA Frontotemporal Disorders Treatment Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Country

  41. MEA Frontotemporal Disorders Treatment Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Drug Class

  42. MEA Frontotemporal Disorders Treatment Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 , By Treatment Type

  43. MEA Frontotemporal Disorders Treatment Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Disease Indication

  44. MEA Frontotemporal Disorders Treatment Market Value (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Distribution Channel

  45. Global Frontotemporal Disorders Treatment Market Valve (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Region

  46. Global Frontotemporal Disorders Treatment Market Valve (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Drug Class

  47. Global Frontotemporal Disorders Treatment Market Valve (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Treatment Type

  48. Global Frontotemporal Disorders Treatment Market Valve (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Disease Indication

  49. Global Frontotemporal Disorders Treatment Market Valve (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028, By Distribution Channel

Frontotemporal Disorders Treatment Market Reports - List of Figures

  1. Global Frontotemporal Disorders Treatment Market Split By Drug Class (2018)

  2. Global Frontotemporal Disorders Treatment Market Split Treatment Type (2018)

  3. Global Frontotemporal Disorders Treatment Market Split By Distribution Channel (2018)

  4. Global Frontotemporal Disorders Treatment Market Split By Disease Indication (2018)

  5. Global Frontotemporal Disorders Treatment Market Split By Region (2018)

  6. Economic Burden of Major Neurological Disease in United States % (2014)

  7. Distribution of Industry Sponsored Clinical Programs for Frontotemporal Disorders Drugs, by Phase

  8. Global Impact of Dementia

  9. Incidence of FTD By Age

  10. Prevalence of Frontotemporal Dementia Across the Globe

  11. Prevalence of Primary Progressive Aphasia (PPA) Across the Globe

  12. North America Frontotemporal Disorders Treatment Market Value Analysis, 2013–2017

  13. North America Frontotemporal Disorders Treatment Market Forecast & Y-o-Y growth, 2018–2028

  14. U.S. Frontotemporal Disorders Treatment Market Value Analysis, 2013–2017

  15. U.S. Frontotemporal Disorders Treatment Market Forecast & Y-o-Y growth, 2018–2028

  16. Canada Frontotemporal Disorders Treatment Market Value Analysis, 2013–2017

  17. Canada Frontotemporal Disorders Treatment Market Forecast & Y-o-Y growth, 2018–2028

  18. North America Frontotemporal Disorders Treatment Market Attractiveness Analysis, By Country

  19. North America Frontotemporal Disorders Treatment Market Attractiveness Analysis, By Drug Class

  20. North America Frontotemporal Disorders Treatment Market Attractiveness Analysis, By Treatment Type

  21. North America Frontotemporal Disorders Treatment Market Attractiveness Analysis, By Disease Indication

  22. North America Frontotemporal Disorders Treatment Market Attractiveness Analysis, By Distribution Channel

  23. Latin America Frontotemporal Disorders Treatment Market Value Analysis, 2013–2017

  24. Latin America Frontotemporal Disorders Treatment Market Forecast & Y-o-Y growth, 2018–2028

  25. Brazil Frontotemporal Disorders Treatment Market Value Analysis, 2013–2017

  26. Brazil Frontotemporal Disorders Treatment Market Forecast & Y-o-Y growth, 2018–2028

  27. Mexico Frontotemporal Disorders Treatment Market Value Analysis, 2013–2017

  28. Mexico Frontotemporal Disorders Treatment Market Forecast & Y-o-Y growth, 2018–2028

  29. Rest of Latin America Frontotemporal Disorders Treatment Market Value Analysis, 2013–2017

  30. Rest of Latin America Frontotemporal Disorders Treatment Market Forecast & Y-o-Y growth, 2018–2028

  31. Latin America Frontotemporal Disorders Treatment Market Attractiveness Analysis, By Country

  32. Latin America Frontotemporal Disorders Treatment Market Attractiveness Analysis, By Drug Class

  33. Latin America Frontotemporal Disorders Treatment Market Attractiveness Analysis, By Treatment Type

  34. Latin America Frontotemporal Disorders Treatment Market Attractiveness Analysis, By Disease Indication

  35. Latin America Frontotemporal Disorders Treatment Market Attractiveness Analysis, By Distribution Channel

  36. Western Europe Frontotemporal Disorders Treatment Market Value Analysis, 2013–2017

  37. Western Europe Frontotemporal Disorders Treatment Market Forecast & Y-o-Y growth, 2018–2028

  38. Germany Frontotemporal Disorders Treatment Market Value Analysis, 2013–2017

  39. Germany Frontotemporal Disorders Treatment Market Forecast & Y-o-Y growth, 2018–2028

  40. Italy Frontotemporal Disorders Treatment Market Value Analysis, 2013–2017

  41. Italy Frontotemporal Disorders Treatment Market Forecast & Y-o-Y growth, 2018–2028

  42. France Frontotemporal Disorders Treatment Market Value Analysis, 2013–2017

  43. France Frontotemporal Disorders Treatment Market Forecast & Y-o-Y growth, 2018–2028

  44. U.K. Frontotemporal Disorders Treatment Market Value Analysis, 2013–2017

  45. U.K. Frontotemporal Disorders Treatment Market Forecast & Y-o-Y growth, 2018–2028

  46. Spain Frontotemporal Disorders Treatment Market Value Analysis, 2013–2017

  47. Spain Frontotemporal Disorders Treatment Market Forecast & Y-o-Y growth, 2018–2028

  48. Rest of Western Europe Frontotemporal Disorders Treatment Market Value Analysis, 2013–2017

  49. Rest of Western Europe Frontotemporal Disorders Treatment Market Forecast & Y-o-Y growth, 2018–2028

  50. Western Europe Frontotemporal Disorders Treatment Market Attractiveness Analysis, By Country

  51. Western Europe Frontotemporal Disorders Treatment Market Attractiveness Analysis, By Drug Class

  52. Western Europe Frontotemporal Disorders Treatment Market Attractiveness Analysis, By Treatment Type

  53. Western Europe Frontotemporal Disorders Treatment Market Attractiveness Analysis, By Disease Indication

  54. Western Europe Frontotemporal Disorders Treatment Market Attractiveness Analysis, By Distribution Channel

  55. Eastern Europe Frontotemporal Disorders Treatment Market Value Analysis, 2013–2017

  56. Eastern Europe Frontotemporal Disorders Treatment Market Forecast & Y-o-Y growth, 2018–2028

  57. Russia Frontotemporal Disorders Treatment Market Value Analysis, 2013–2017

  58. Russia Frontotemporal Disorders Treatment Market Forecast & Y-o-Y growth, 2018–2028

  59. Poland Frontotemporal Disorders Treatment Market Value Analysis, 2013–2017

  60. Poland Frontotemporal Disorders Treatment Market Forecast & Y-o-Y growth, 2018–2028

  61. Rest of Eastern Europe Frontotemporal Disorders Treatment Market Value Analysis, 2013–2017

  62. Rest of Eastern Europe Frontotemporal Disorders Treatment Market Forecast & Y-o-Y growth, 2018–2028

  63. Eastern Europe Frontotemporal Disorders Treatment Market Attractiveness Analysis, By Country

  64. Eastern Europe Frontotemporal Disorders Treatment Market Attractiveness Analysis, By Drug Class

  65. Eastern Europe Frontotemporal Disorders Treatment Market Attractiveness Analysis, By Treatment Type

  66. Eastern Europe Frontotemporal Disorders Treatment Market Attractiveness Analysis, By Disease Indication

  67. Eastern Europe Frontotemporal Disorders Treatment Market Attractiveness Analysis, By Distribution Channel

  68. APEJ Frontotemporal Disorders Treatment Market Value Analysis, 2013–2017

  69. APEJ Frontotemporal Disorders Treatment Market Forecast & Y-o-Y growth, 2018–2028

  70. China Frontotemporal Disorders Treatment Market Value Analysis, 2013–2017

  71. China Frontotemporal Disorders Treatment Market Forecast & Y-o-Y growth, 2018–2028

  72. India Frontotemporal Disorders Treatment Market Value Analysis, 2013–2017

  73. India Frontotemporal Disorders Treatment Market Forecast & Y-o-Y growth, 2018–2028

  74. Australia Frontotemporal Disorders Treatment Market Value Analysis, 2013–2017

  75. Australia Frontotemporal Disorders Treatment Market Forecast & Y-o-Y growth, 2018–2028

  76. ASEAN Frontotemporal Disorders Treatment Market Value Analysis, 2013–2017

  77. ASEAN Frontotemporal Disorders Treatment Market Forecast & Y-o-Y growth, 2018–2028

  78. Rest of APEJ Frontotemporal Disorders Treatment Market Value Analysis, 2013–2017

  79. Rest of APEJ Frontotemporal Disorders Treatment Market Forecast & Y-o-Y growth, 2018–2028

  80. APEJ Frontotemporal Disorders Treatment Market Attractiveness Analysis, By Country

  81. APEJ Frontotemporal Disorders Treatment Market Attractiveness Analysis, By Drug Class

  82. APEJ Frontotemporal Disorders Treatment Market Attractiveness Analysis, By Treatment Type

  83. APEJ Frontotemporal Disorders Treatment Market Attractiveness Analysis, By Disease Indication

  84. APEJ Frontotemporal Disorders Treatment Market Attractiveness Analysis, By Distribution Channel

  85. Japan Frontotemporal Disorders Treatment Market Value Analysis, 2013–2017

  86. Japan Frontotemporal Disorders Treatment Market Forecast & Y-o-Y growth, 2018–2028

  87. Japan Frontotemporal Disorders Treatment Market Attractiveness Analysis, By Disease Indication

  88. Japan Frontotemporal Disorders Treatment Market Attractiveness Analysis, By Treatment Type

  89. Japan Frontotemporal Disorders Treatment Market Attractiveness Analysis, By Drug Class

  90. Japan Frontotemporal Disorders Treatment Market Attractiveness Analysis, By Distribution Channel

  91. MEA Frontotemporal Disorders Treatment Market Value Analysis, 2013–2017

  92. MEA Frontotemporal Disorders Treatment Market Forecast & Y-o-Y growth, 2018–2028

  93. GCC Countries Frontotemporal Disorders Treatment Market Value Analysis, 2013–2017

  94. GCC Countries Frontotemporal Disorders Treatment Market Forecast & Y-o-Y growth, 2018–2028

  95. South Africa Frontotemporal Disorders Treatment Market Value Analysis, 2013–2017

  96. South Afric Frontotemporal Disorders Treatment Market Forecast & Y-o-Y growth, 2018–2028

  97. Rest of MEA Frontotemporal Disorders Treatment Market Value Analysis, 2013–2017

  98. Rest of MEA Frontotemporal Disorders Treatment Market Forecast & Y-o-Y growth, 2018–2028

  99. MEA Frontotemporal Disorders Treatment Market Attractiveness Analysis, By Country

  100. MEA Frontotemporal Disorders Treatment Market Attractiveness Analysis, By Drug Class

  101. MEA Frontotemporal Disorders Treatment Market Attractiveness Analysis, By Treatment Type

  102. MEA Frontotemporal Disorders Treatment Market Attractiveness Analysis, By Disease Indication

  103. MEA Frontotemporal Disorders Treatment Market Attractiveness Analysis, By Distribution Channel

  104. Global Frontotemporal Disorders Treatment Market Attractiveness Analysis, By Region

  105. Global Frontotemporal Disorders Treatment Market Attractiveness Analysis, By Drug Class

  106. Global Frontotemporal Disorders Treatment Market Attractiveness Analysis, By Treatment Type

  107. Global Frontotemporal Disorders Treatment Market Attractiveness Analysis, By Disease Indication

  108. Global Frontotemporal Disorders Treatment Market Attractiveness Analysis, By Distribution Channel

  109. Global Frontotemporal Disorders Treatment Market Historical Market Value and Y-o-Y, 2013-2018

  110. Global Frontotemporal Disorders Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028

  111. Global Frontotemporal Disorders Treatment Market Absolute $ Opportunity, 2013–2028

Get in touch

Harish Tiwari

Global Head - Business Development

+44 (0) 20 3287 4268

Pranay Mhaisekar

Business Development

+ 44 (0) 20 7692 8790
* indicates mandatory fields.

Latest Insights

Our Clients

Press Releases:

Recommendations

CASE STUDIES

See how our work makes an impact.

At FMI, we design strategies that are adaptive, impactful, and implementable.

Learn More
Request Sample Ask An Analyst Request Special Price Request Methodology